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Psychological Stress with Long-Standing Allergic
Dermatitis Causes Psychodermatological Conditions
in Mice
Hideki Kitagaki1,2, Hidetaka Hiyama1, Toshiki Kitazawa1 and Tetsuo Shiohara2
Psychological factors have long been assumed to be involved in the pathogenesis of allergic skin diseases. The
effects of psychological stress on allergic contact dermatitis (ACD) have been experimentally well investigated;
however, the effects of ACD on stress responses are largely unknown. Here, we report that preceding chronic
ACD dramatically affects the behavioral and physiological stress responses to social isolation (a psychological
stressor). In male BALB/c mice, social isolation combined with long-standing (42 months) ACD by repeated
hapten application caused characteristic symptoms, including chronic dermatitis from persistent self-scratching,
behavioral changes related to fear/anxiety, and elevated serum IgE levels. The symptoms were maintained by
social isolation alone without further hapten application after the onset, and were improved by resocialization.
Treatment with topical corticosteroids exacerbated chronic scratch dermatitis, whereas it was effective for
chronic ACD. These results show that the symptoms represent a de novo development of a specific disease state
and not a mere exacerbation of a preexisting allergic inflammation. With this experimental protocol, similar
results were obtained in several other strains of mice. This murine model provides a tool for investigating the
pathogenesis and treatment of allergic skin disease with psychodermatological aspects.
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INTRODUCTION
In the last two decades, there has been great progress in the
understanding of the etiopathogenesis of allergic skin diseases
such as allergic contact dermatitis (ACD) and atopic dermatitis
(AD), especially concerning the genetic factors and molecular
mechanisms underlying the skin barrier and immune abnorm-
alities (Bieber, 2008; Boguniewicz and Leung, 2011). A better
insight into the pathogenesis and treatment has been made
possible by the different murine models (Shiohara et al., 2004;
Jin et al., 2009; Dubrac et al., 2010). Although each of these
models has some features that are characteristic of human
inflammatory skin disorders, there is no suitable animal model
in which to examine the effect of the complex interaction
between immunological and psychological factors on the
development of psychodermatological conditions. There is
increasing evidence to support the bidirectional relation
between psychological factors and inflammatory skin
disorders; e.g., psychological stress can trigger or exacerbate
AD symptoms, and AD is associated with significant
psychiatric morbidity (Hashizume and Takigawa, 2006; Ring
et al., 2006; Chida et al., 2008; Yaghmaie et al., 2013). In the
search for more clinically relevant models of human skin
disorders, it is clear that the scope must be broadened from
classic ‘‘inflammatory’’ models to encompass the wide range
of psycho–neuro–endocrine–immunological factors.
AD affects up to 20% of children worldwide, and the
prevalence is increasing especially in developing countries
(Asher et al., 2006). Such an increase in prevalence cannot be
explained only by genetic factors. The most recent US data
(Shaw et al., 2011) also showed a wide range of prevalence of
AD (9–18%) and its association with metropolitan living,
higher education, and black ethnicity, suggesting that social
or environmental factors can affect the expression of AD.
Similarly, many previous studies have reported an increase in
AD prevalence in urban areas compared with rural areas
(Schram et al., 2010). Moreover, mental disorders such as
mood and anxiety disorders are also more prevalent among
city dwellers (Peen et al., 2010), and the incidence of
schizophrenia is strongly increased in persons born and
raised in cities (Krabbendam and van Os, 2005). In this
regard, a recent neuroimaging study revealed that city living
and an urban upbringing affect neural social stress processing
(Lederbogen et al., 2011). These findings imply that daily life
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stress, in addition to allergic sensitization, is crucial for the
development of human allergic disease and related psycho-
dermatological disorders. To investigate this possibility, it is
necessary to establish an animal model for psychodermato-
logical disorders in which the bidirectional interaction
between psychological stress and allergic inflammation is
directly involved in the pathogenesis.
During the last 20 years, our laboratory has been involved
in the analysis of a murine model for chronic ACD (Kitagaki
et al., 1995, 1997; Shiohara et al., 2004). In this model,
a human AD-like inflammation characterized by chronic
eczema, increased serum IgE levels, and Th2-dominated
immune responses is induced by repeated hapten challenge.
The onset and maintenance of the inflammatory state depend
on the hapten application, and the inflammation rapidly
resolves after the cessation of hapten application. During the
resolution process, however, we noted that some of these
mice when housed alone maintained skin lesions along
with severe scratching behavior despite no further hapten
application. Because social isolation, such as by housing the
animals individually, represents a psychological stress for
rodents (Hall, 1998), we interpreted this finding as indicating
that psychological stress in conjunction with chronic allergic
inflammation leads to a specific disease state. On the basis of
this idea, we established a murine model in which allergic
dermatitis and psychological stress are directly involved as
triggering and perpetuating factors of psychodermatological
conditions.
RESULTS
Social isolation during the progression of chronic ACD causes
idiopathic dermatitis at unchallenged skin sites
To initially investigate the effect of social isolation on chronic
ACD, male BALB/c mice were assigned to either individual
housing (IH) or group housing (GH) conditions, and repeatedly
challenged on the right ear with 2,4,6-trinitrochlorobenzene
(TNCB) at 2-day intervals. In IH mice, but not in GH mice,
‘‘idiopathic dermatitis’’ that was accompanied by severe
scratching developed at unchallenged skin sites, such as the
left ear, head, and face, but rarely on the trunk, as shown by
increases in left ear thickness (Figure 1a) and clinical skin
score (Figure 1b). Untreated normal mice in either IH or GH
conditions did not show any signs of skin symptoms (data not
shown). The skin lesions of idiopathic dermatitis were qualita-
tively distinct from those of chronic ACD; these included
excoriation, ulcer, scab, scar, small hemorrhage, and/or
alopecia (Figure 1c). There was a delay of about 8 weeks
between the initiation of hapten challenge/IH and the
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Figure 1. Effect of social isolation during the progression of chronic allergic contact dermatitis. Mice were assigned to either individual housing (IH)
or group housing (GH) conditions (n¼ 16 each), and repeatedly challenged on the right ear with 2,4,6-trinitrochlorobenzene at 2-day intervals for 28 weeks.
(a) Changes in left and right ear thickness. (b) Changes in total clinical skin score for the left ear, head, right face, and left face. (a, b) **Po0.01, repeated-measures
analysis of variance. (c) Photographs of IH and GH mice at 20 weeks.
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onset of idiopathic dermatitis, suggesting that a sufficient dura-
tion of ACD, social isolation, or both is required for the onset.
Idiopathic dermatitis is triggered by social isolation immediately
after long-standing ACD and maintained by social isolation
alone
We next examined the timing of exposure to social isolation
necessary for the subsequent development of idiopathic
dermatitis. IH, when started immediately after the cessation
of repeated hapten challenge, triggered idiopathic dermatitis,
which developed without a delay of weeks after IH and persis-
ted for 28 weeks (Figure 2a–c). In contrast, IH, when started
4 weeks after the cessation of the hapten challenge, did not
induce idiopathic dermatitis (data not shown). Resocialization
(i.e., transfer from IH to GH conditions), when initiated
4 months after the onset, significantly improved the idiopathic
dermatitis (Figure 2d).
To investigate the duration of chronic ACD required for the
subsequent development of idiopathic dermatitis, mice were
repeatedly challenged with TNCB for various durations
(30–180 days) under GH conditions, and then they were
transferred to IH conditions immediately after the cessation of
the hapten challenge. Repeated challenge for at least 60 days
was required to induce idiopathic dermatitis. The incidence
and clinical skin score increased as the duration of hapten
challenge increased up to 120 days (Figure 2e).
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Figure 2. Effect of social isolation immediately after chronic allergic contact dermatitis (ACD). (a–c) Mice subjected to 12 weeks of ACD were
subsequently exposed to individual housing (IH) (n¼ 16) or continuous group housing (GH) conditions (n¼15). (d) Mice with established idiopathic dermatitis
induced by 12 weeks of ACD and subsequent 17 weeks of IH were assigned to either resocialization (n¼ 6) or continuous IH conditions (n¼ 5). (e) Mice
subjected to ACD for various durations (30–180 days; n¼ 11–17) were exposed to 7 weeks of IH. (a, b, d) **Po0.01, repeated-measures analysis of variance
(ANOVA). (e) *Po0.05, **Po0.01 versus unchallenged mice (0 day), Fisher’s exact test with Bonferroni correction or one-way ANOVA followed by
Dunnett’s test.
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Taken together, these results demonstrate that idiopathic
dermatitis is (1) triggered by social isolation combined
with chronic ACD which persists for at least 2 months,
(2) maintained by social isolation alone without further hapten
application, and (3) improved by resocialization. Idiopathic
dermatitis is considered to represent the de novo development
of a specific disease state and not a mere exacerbation of
preexisting ACD.
In further experiments, the disease state was induced by
42 months of chronic ACD and 42 months of IH immedi-
ately after the cessation of the ACD challenge (AI mice), unless
stated otherwise. The control mice included age-matched
normal mice in GH (NG mice) or IH conditions (NI mice),
and mice in GH conditions that had been subjected to chronic
ACD for the same period (AG mice).
Idiopathic dermatitis is caused by self-scratching
An intense and long-lasting behavior of scratching with the
hind limbs was frequently observed in AI mice, and there was
a significant correlation between the number of scratching
events and the clinical skin score (Figure 3a), implying that
idiopathic dermatitis in AI mice was induced by self-scratch-
ing. To prove this, a plastic collar was placed on each mouse
to prevent scratching of the ears, head, and face (Figure 3b).
As a result, the idiopathic dermatitis improved with time and
disappeared completely after 8 weeks (Figure 3c and d).
However, the scratching behind the collar continued through-
out the experiment, and after removal of the collar the
skin lesions rapidly relapsed (Figure 3d), suggesting that the
desire to scratch persisted even after the complete resolution
of skin symptoms. These results demonstrate that idiopathic
dermatitis is caused by self-scratching, which is consistent
with the diagnosis of scratch dermatitis based on macroscopic
and histological features of the skin lesions (Supplementary
Figure S1 online).
AI mice show low body weight and behavioral, endocrine, and
immune abnormalities
AI mice had a significantly lower body weight compared with
age-matched control mice (Figure 4a and b), and there was
a significant correlation between body weight and clinical
skin score (Figure 4c). Resocialization restored the body
weight of AI mice significantly (Figure 4d).
AI mice also showed the following behavioral changes
compared with NI mice: a frequent appearance of fear
behaviors during human handling, such as freezing, vocaliza-
tion, urination, and defecation (Figure 4a); an increase in
defecation during novel environment exploration (Figure 4e),
which indicates increased anxiety-like behavior (Okuyama
et al., 1999); a lack of nest-building behavior (Figure 4f); and a
change in the circadian pattern of locomotor activity (hypoac-
tivity in the dark phase and hyperactivity in the light phase;
Figure 4g). Furthermore, basal plasma corticosterone levels
were significantly higher in AI mice than in control mice
(Figure 4h). There was no significant correlation between
corticosterone levels and clinical skin scores in AI mice,
which may be due to the technical limitation of blood
sampling in the presence of artificial disturbances.
Serum total IgE levels were markedly increased by repeated
hapten challenge (Shiohara et al., 2004) and decreased after
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Figure 3. Idiopathic dermatitis is induced by self-scratching. (a) Correlation between the number of scratching events and total clinical skin score for the right
and left ear in AI mice 6–7 weeks after individual housing exposure (n¼ 37). Simple linear regression analysis. (b) Photograph of a mouse wearing a plastic
collar to prevent scratching of the ears, head, and face. (c) Changes in total clinical skin score for the right and left ear in AI mice wearing a collar
(n¼ 10) or untreated (n¼ 7). **Po0.01, repeated-measures analysis of variance. (d) Photographs of the ear before (left) and 12 weeks after wearing a collar
(middle), and 4 days after removing the collar (right).
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the cessation of the challenge. However, the levels were
maintained significantly higher in AI mice than in AG mice
(Figure 4i). There was a significant correlation between serum
total IgE levels and the clinical skin score in AI mice
(Figure 4j). In addition, the total IgE and IL-4 productions by
splenocytes were much higher in AI mice than in control mice
(Supplementary Figure S2 online). Importantly, the serum total
IgE levels in AI mice were significantly reduced by resociali-
zation (Figure 4k), but not by prevention of scratching
(Figure 4l), showing that the immunological change is depen-
dent on psychological stress but not skin inflammation.
Topical corticosteroid treatment improves chronic ACD but
exacerbates chronic scratch dermatitis
To evaluate the effect of topical corticosteroid on chronic
ACD and the subsequent development of psychodermato-
logical conditions, 0.1% betamethasone-17-valerate (BV)
was topically applied to the challenged right ear once daily.
The treatment markedly improved the chronic ACD and
simultaneously prevented the onset of idiopathic dermatitis
(Figure 5a).
Next, to evaluate the therapeutic effect on established
chronic skin lesions in AI mice, which is considered to be
‘‘pure’’ scratch dermatitis, 0.1% BV was topically applied to
the right and left ears once daily for 6 weeks. Unexpectedly,
the treatment resulted in an exacerbation of the skin lesions, as
evidenced by a significant increase in the clinical skin score
(Figure 5b) and distinctive macroscopic features: development
of necrotic skin lesions and reduction in the size of the ear
pinna (Figure 5e). We also compared the dose-response effects
of BV on chronic scratch dermatitis with those on chronic
ACD. The lower doses of BV (0.001% or 0.01%) showed no
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significant effects on the chronic scratch dermatitis, and 0.1%
BV exacerbated it in the same fashion (Figure 5c), whereas
0.001% to 0.1% BV significantly suppressed chronic ACD
(Figure 5d).
Idiopathic dermatitis can be induced with another hapten or in
some other mouse strains
Finally, to test the generality of our experimental protocol, we
evaluated the incidence of idiopathic dermatitis with different
chemicals or mouse strains (Supplementary Table S1 online).
The use of oxazolone, a different hapten, instead of TNCB
induced idiopathic dermatitis with a similar incidence,
whereas 12-O-tetradecanoylphorbol-13-acetate, a primary
irritant, did not cause the development of idiopathic derma-
titis, although it induced chronic dermatitis on the challenged
right ear comparable to that induced by TNCB. Idiopathic
dermatitis could also be induced in some other mouse strains,
including in mast cell–deficient mice (Supplementary Figure
S3 online); however, there were clear differences in incidence
among mouse strains. On the other hand, female BALB/c mice
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showed a lower incidence of idiopathic dermatitis compared
with male mice. These results indicate that this pathological
event is a general phenomenon neither limited to the BALB/c
strain nor to a specific hapten, although there are some strain
and sex differences in the susceptibility.
DISCUSSION
The nervous and immune systems interact in a bidirectional
fashion; various inflammatory diseases, including skin dis-
orders, are influenced by psychological stress, and vice versa
produce mental problems (Ader et al., 1995; Chida et al.,
2008). The effects of stress on ACD have been experimentally
well investigated in rodents, the results of which demonstrate
that ACD is differentially influenced by different types and
durations of stressors; e.g., acute restraint stress enhances,
whereas chronic restraint stress suppresses, ACD (Dhabhar
and McEwen, 1997), and acute isolation stress suppresses,
whereas chronic isolation stress enhances, ACD (Nakano,
2004). In contrast, the effects of ACD on stress responses have
been poorly investigated in animal models. In this study, we
demonstrated that preceding chronic ACD dramatically affects
the behavioral and physiological stress responses to a
psychological stressor (social isolation).
Social isolation is known to produce wide-ranging beha-
vioral and neuroendocrine effects in rodents depending on the
developmental stage of the animals: social isolation during the
preweaning or early postweaning period profoundly affects
brain development and adult behavior, whereas that during
adulthood produces relatively mild and reversible changes
(Hall, 1998; Fone and Porkess, 2008; Lukkes et al., 2009).
Indeed, it has been reported that serum corticosterone levels
are elevated by short-term social isolation (2 days), but are
returned to the normal range by long-term social isolation
(1 month) in adult mice (Nakano, 2004). Likewise, in our
experiments, social isolation (42 months) had no significant
effect on plasma corticosterone levels and body weight in
normal mice. In mice subjected to long-standing ACD, how-
ever, social isolation induced significant elevation of cortico-
sterone levels and weight loss, in addition to behavioral
changes such as increased self-scratching and anxiety-related
behaviors. These results show that chronic ACD leads to
substantial changes in stress responses to social isolation.
Chronic ACD by repeated hapten application causes a
shift from a Th1-dominated to a Th2-dominated immune
response (Kitagaki et al., 1997). In the chronic ACD model,
serum levels of IgE, which predominantly reflect activation of
Th2 immunity, gradually increase up to 4 months during
repeated hapten application (data not shown)—a time period
similar to that when the incidence of idiopathic dermatitis
reaches a peak. In contrast, chronic irritant contact dermatitis
by repeated 12-O-tetradecanoylphorbol-13-acetate applica-
tion does not influence stress responses to social isolation.
These findings suggest that overactivation of Th2 immune
responses by long-standing allergic inflammation leads to
changes in stress responses to social isolation. In addition,
the Th2 dominance, characterized by elevated levels of serum
IgE and IL-4 production from splenocytes, is maintained by
social isolation alone without further hapten application after
the onset of psychodermatological conditions. Because stress
hormones such as glucocorticoid and catecholamines can
influence the Thl/Th2 balance (Calcagni and Elenkov, 2006), a
vicious circle between the Th2 dominance and psychological
stress may be involved in the pathogenesis of psychodermato-
logical conditions in this model.
Pruritus is one of the most troublesome symptoms of skin
disorders such as AD that substantially impair the patients’
quality of life (Koblenzer, 1999). Sleep loss that accompanies
nighttime scratching can lead to daytime fatigue, mood
disorder, and poor school or work performance (Bender
et al., 2008; Slattery et al., 2011). Our model reproduces
these pruritus-related symptoms, such as persistent scratching
behavior, and disturbed circadian pattern and nest building.
The causes of chronic pruritus can be broadly categorized
into four major groups: dermatologic, systemic, neuropathic,
and psychogenic (Yosipovitch and Bernhard, 2013). The
‘‘pruritus’’ in this model seems to have both psychogenic
and dermatologic causes, because (1) social isolation is critical
for onset and maintenance and (2) scratch dermatitis develops
on untreated normal skin sites (although it localizes around
the hapten-challenged right ear) such as the left ear, head, and
face, but rarely on the trunk. In this regard, recent studies
have suggested the existence of a ‘‘central sensitization to
itch’’ in chronic pruritus (Ikoma et al., 2006; Paus et al., 2006;
Schmelz, 2010). This mechanism may be involved in the
pathogenesis of pruritus in this model, in which we assume
that long-standing repeated pruritic stimuli by ACD facilitate
central itch processing involving pathways around the
originally activated one, and the subsequent psychological
disturbances further lowers the threshold, resulting in
chronic pruritus evoked by innocuous stimuli, such as tactile
stimuli perceived by low-threshold mechanoreceptors
(A–b fibers). In fact, a light tactile stimulus easily evokes
scratching or head-shaking behavior in AI mice (data not
shown).
Chronic pruritus leads to persistent scratching and conse-
quent variable skin damage (scratch dermatitis; Stander et al.,
2007). Clinically, scratch dermatitis generally coexists with
primary skin lesions such as allergic dermatitis, making it
difficult to investigate them separately. It is therefore important
to experimentally dissect scratch dermatitis to directly address
whether conventional treatment such as topical corticosteroids
is indeed beneficial to it as well as to allergic dermatitis. In this
study, we show that topical treatment with corticosteroids
has no beneficial effects on ‘‘pure’’ chronic scratch dermatitis
in AI mice, whereas it suppresses chronic ACD. Consistent
with this, it is known that human skin lesions that may be
induced by prolonged scratching, such as prurigo nodularis,
lichen simplex chronicus, or lichen amyloidosus, are
highly resistant to therapy (Lotti et al., 2008; Yosipovitch
and Bernhard, 2013), although topical corticosteroids are
extremely effective for severe flares of AD. Finally, the intrac-
table psychodermatological symptoms, including scratch
dermatitis, in this model can be restored by removing the
social isolation stressor (resocialization); likewise, psycho-
logical interventions have been reported to be beneficial for
patients with pruritic skin disorders such as AD, although
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further studies are needed to explore and evaluate the
appropriate strategies (Chida et al., 2007; Ersser et al., 2007;
Lavda et al., 2012).
The results of this study indicate that there are at least two
distinct disease states in our mouse model: an ‘‘inflammatory
disease state’’ driven by allergic dermatitis and a ‘‘psychiatric
disease state’’ driven mainly by psychological stress. The use
of controllable environmental factors (hapten application and
social isolation) with predisposing genetic factors (male BALB/
c mice) makes it possible to develop and dissect both disease
states in this model. In the psychiatric disease state (i.e.,
psychodermatological conditions), elevated IgE levels are
maintained by social isolation alone without further hapten
application and improved by resocialization but not by
prevention of scratching, suggesting a differential regulation
of IgE that is more dependent on psychological factors than
the initial skin barrier perturbation and subsequent cutaneous
inflammation. This infers that such psychiatric disease states
underlie the development of intractable symptoms in human
allergic skin diseases such as ACD and AD. The psychosocial
stress associated with city living and modern lifestyles may
have a strong impact on the development of allergic disorders
and offer a potential target for interventions designed to
reduce the prevalence in westernized countries. Our model
provides a tool for investigating the pathogenesis and treat-
ment of allergic skin disease with psychodermatological
aspects.
MATERIALS AND METHODS
Mice and housing conditions
Male BALB/c mice were purchased from Charles River Japan
(Yokohama, Japan) or CLEA Japan (Tokyo, Japan) at 5 weeks of age.
All mice were housed in groups of 6–11 per cage (22 38 20 cm)
and acclimated for at least 1 week before use. In each experiment,
some mice were transferred from GH to IH conditions in smaller
cages (18 28 13 cm or 10 18 11 cm). Animals were main-
tained under specific pathogen-free conditions on a 12-hour light/
dark cycle (lights on at 06:30 am and off at 18:30 pm) and received
food and water ad libitum. The protocols of this study were approved
by the Institutional Ethics Committee on Animal Experiments, and all
procedures were in accordance with the Guidelines for Animal Care
and Use of Otsuka Pharmaceutical.
Induction of chronic ACD
Mice were sensitized by a single epicutaneous application of
20ml of 1% TNCB (Tokyo Chemical Industry, Tokyo, Japan) in
acetone to the right ear 7 days before the first challenge, and then
repeatedly challenged with 20ml of 1% TNCB on the right ear at
2-day intervals. Because repeated hapten application induces
severe dermatitis, the treated area was restricted to the right ear
pinna (B3% of all skin surface areas). The left ear and other skin sites
were left untreated.
Ear thickness
Ear thickness was measured with a dial thickness gauge (Ozaki MFG,
Tokyo, Japan) under light anesthesia with diethyl ether. During the
period of hapten challenge, the measurement was performed just
before each challenge.
Clinical skin score
To assess the severity of idiopathic dermatitis (scratch dermatitis), we
used the following clinical skin score based on the area of skin lesions
with scratch-induced damage, such as ulcers, excoriations, erosion,
small hemorrhages, crusts, or scabs: score for the left ear or the right
ear (0¼ no lesion, 1¼ lesion areao12.5%, 2¼ lesion area from 12.5
to 25%, 3¼ lesion area from 25 to 50%, 4¼ lesion area X50%) and
score for the head, left face, or right face (0¼ no lesion, 1¼ lesion
area o50%, 2¼ lesion area X50%). The incidence of idiopathic
dermatitis was calculated from the number of mice with a total
clinical skin score X2.
Scratching behavior
The observations of scratching behavior were made 0.5 to 2 h after
lights-off in a 12-hour light/dark cycle. Mice in their familiar home
cages were video-recorded using an infrared camera (VC-D900;
Sanyo, Osaka, Japan) without human disturbance. Only scratching
of the right or left ear with the hind limbs was counted for 30–60 min.
Mice generally showed a series of scratches for a second; therefore, a
series of scratching movements between lifting the hind limb and
putting it down was counted as one event (Kuraishi et al., 1995).
Emotional defecation
Mice were transferred individually from their home cages to a novel
environment (18 28 13-cm cage with a clean aluminum foil sheet
on the floor), and allowed to freely explore the environment for
10 min. The number of fecal boli excreted during the period was
counted.
Nest-building behavior
Under IH conditions, normal mice consistently formed an identifiable
nest in a new cage by using shredded strips of paper chips for
bedding. To assess this nest-building behavior, one week after each
mouse was moved to a new clean cage with fresh paper chip bedding
the cage was checked for the presence of a newly built nest.
Locomotor activity
The locomotor activity of the mice was measured using a Supermex
system (Muromachi Kikai, Tokyo, Japan). The infrared sensors
were placed above their home cages, and locomotor activity was
monitored continuously over 24 hours without human disturbance.
Basal plasma corticosterone levels
Between 0830 hr and 1100 hr, blood was collected from the tail vein
within 2 min after mice were removed from their home cages. The
plasma was stored at  80 1C until analyzed. The samples were
extracted with diethyl ether, evaporated, reconstituted in assay buffer,
and determined by ELISA using goat anti-rabbit IgG (1.5mg ml 1;
Vector Laboratories, Burlingame, CA), horseradish peroxidase-labeled
corticosterone (0.1mg ml 1; Cosmo Bio, Tokyo, Japan), and rabbit
anti-corticosterone IgG (1:600,000, Cosmo Bio), according to the
manufacturer’s instructions.
Serum total IgE levels
Blood was collected from the tail vein, and the serum was stored
at  80 1C until analyzed. Serum levels of total IgE were measured
using an ELISA kit (OptEIA; BD Pharmingen, San Diego, CA)
according to the manufacturer’s instructions.
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Topical corticosteroid treatment
BV (Sigma-Aldrich Japan, Tokyo, Japan) dissolved in acetone/
methanol (1:1, v/v) was epicutaneously applied on the ears of mice
(20ml per ear, once daily).
Statistics
Data are presented as mean±SEM. All statistical analyses were
performed using SAS software (SAS Institute Japan, Tokyo, Japan).
Po0.05 was considered statistically significant.
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